Literature DB >> 16756089

Development of a human mammary epithelial cell culture model for evaluation of drug transfer into milk.

Soichiro Kimura1, Keiko Morimoto, Hiroshi Okamoto, Hideo Ueda, Daisuke Kobayashi, Jun Kobayashi, Yasunori Morimoto.   

Abstract

In the present study, a human mammary epithelial cell (HMEC) culture model was developed to evaluate the potential involvement of carrier-mediated transport systems in drug transfer into milk. Trypsin-resistant HMECs were seeded on Matrigel-coated filters to develop monolayers of functionally differentiated HMEC. Expression of the specific function of HMEC monolayers was dependent of the number of trypsin treatments. Among the monolayers with different numbers of treatment (treated 1 to 3 times), the monolayer treated 3 times (3-t-HMEC monolayer) showed the highest maximal transepithelial resistance and expression of beta-casein mRNA as an index of differentiation. Transport of tetraethylammonium (TEA) across the 3-t-HMEC monolayer in the basolateral-to-apical direction was significantly higher than that in the apical-to-basolateral direction (p < 0.05), whereas such directionality was not observed for p-amino-hippurate, suggesting the existence of organic cation transporters, but not organic anion transporters. In fact, expression of mRNAs of human organic cation transporter (OCT) 1 and 3 were detected in the 3-t-HMEC monolayer. These results indicate that the 3-t-HMEC monolayer is potentially useful for the evaluation of carrier-mediated secretion of drugs including organic cations into human milk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16756089     DOI: 10.1007/bf02968594

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  8 in total

Review 1.  Drugs in Lactation.

Authors:  Philip O Anderson
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

2.  Molecular and functional identification of organic anion transporter isoforms in cultured bovine mammary epithelial cells (BME-UV).

Authors:  M M Al-Bataineh; D Van Der Merwe; B D Schultz; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2011-05-30       Impact factor: 1.786

3.  Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells.

Authors:  Mohammad M Al-Bataineh; Deon van der Merwe; Bruce D Schultz; Ronette Gehring
Journal:  Biopharm Drug Dispos       Date:  2010-10-22       Impact factor: 1.627

4.  An in vitro human mammary epithelial cell permeability assay to assess drug secretion into breast milk.

Authors:  Tao Zhang; Zachary Applebee; Peng Zou; Zhen Wang; Erika Solano Diaz; Yanyan Li
Journal:  Int J Pharm X       Date:  2022-06-22

5.  Infant Dextromethorphan and Dextrorphan Exposure via Breast Milk From Mothers Who Are CYP2D6 Extensive Metabolizers.

Authors:  Sara Shum; Aprajita Yadav; Emily Fay; Sue Moreni; Jennie Mao; Lindsay Czuba; Celine Wang; Nina Isoherranen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2022-01-08       Impact factor: 2.860

6.  Cultured mammary epithelial monolayers (BME-UV) express functional organic anion and cation transporters.

Authors:  M M Al-Bataineh; D van der Merwe; B D Schultz; R Gehring
Journal:  J Vet Pharmacol Ther       Date:  2009-10       Impact factor: 1.786

7.  The use of herbal medicines during breastfeeding: a population-based survey in Western Australia.

Authors:  Tin Fei Sim; Jillian Sherriff; H Laetitia Hattingh; Richard Parsons; Lisa B G Tee
Journal:  BMC Complement Altern Med       Date:  2013-11-13       Impact factor: 3.659

8.  Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.

Authors:  Imke H Bartelink; Brendan Prideaux; Gregor Krings; Lisa Wilmes; Pei Rong Evelyn Lee; Pan Bo; Byron Hann; Jean-Philippe Coppé; Diane Heditsian; Lamorna Swigart-Brown; Ella F Jones; Sergey Magnitsky; Ron J Keizer; Niels de Vries; Hilde Rosing; Nela Pawlowska; Scott Thomas; Mallika Dhawan; Rahul Aggarwal; Pamela N Munster; Laura J Esserman; Weiming Ruan; Alan H B Wu; Douglas Yee; Véronique Dartois; Radojka M Savic; Denise M Wolf; Laura van 't Veer
Journal:  Breast Cancer Res       Date:  2017-09-11       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.